Background-Diabetic patients have an increased risk of developing atherosclerosis and related complications compared with nondiabetic individuals. The increased cardiovascular risk associated with diabetes is due in part to genetic variations that influence both glucose homeostasis and atherosclerotic lesion growth. Mouse strains C57BL/6J (B6) and BALB/cJ (BALB) exhibit distinct differences in fasting plasma glucose and atherosclerotic lesion size when deficient in apolipoprotein E (Apoe Ϫ/Ϫ ). Quantitative trait locus (QTL) analysis was performed to determine genetic factors influencing the 2 phenotypes. Methods and Results-Female F 2 mice (nϭ266) were generated from an intercross between B6.Apoe Ϫ/Ϫ and BALB.Apoe Ϫ/Ϫ mice and fed a Western diet for 12 weeks. Atherosclerotic lesions in the aortic root, fasting plasma glucose, and body weight were measured. 130 microsatellite markers across the entire genome were genotyped. Four significant QTLs, Ath1 on chromosome (Chr) 1, Ath41 on Chr2, Ath42 on Chr5, and Ath29 on Chr9, and 1 suggestive QTL on Chr4, were identified for atherosclerotic lesion size. Four significant QTLs, Bglu3 and Bglu12 on Chr1, Bglu13 on Chr5, Bglu15 on Chr12, and 2 suggestive QTLs on Chr9 and Chr15 were identified for fasting glucose levels on the chow diet. Two significant QTLs, Bglu3 and Bglu13, and 1 suggestive locus on Chr8 were identified for fasting glucose on the Western diet. One significant locus on Chr1 and 2 suggestive loci on Chr9 and Chr19 were identified for body weight. Ath1 and Ath42 coincided with Bglu3 and Bglu13, respectively, in the confidence interval. Conclusions-We have identified novel QTLs that have major influences on atherosclerotic lesion size and glucose homeostasis. The colocalization of QTLs for atherosclerosis and diabetes suggests possible genetic connections between the 2 diseases. (Circ Cardiovasc Genet. 2012;5:190-201.)
T ype 2 diabetes mellitus (T2DM) is a major risk factor for atherosclerotic cardiovascular disease. Diabetic patients have a 2-to 4-fold higher risk of developing atherosclerosis and its complications compared with nondiabetic individuals. 1 Part of the increased cardiovascular risk associated with diabetes is due to genetic variations that influence both glucose homeostasis and the development of atherosclerosis. A few rare gene mutations result in both early coronary heart disease and T2DM that are observable as mendelian traits segregating in families, which include LRP6, 2 ABCA1, 3, 4 and APOB. 5 Recent genome-wide association studies (GWAS) have identified dozens of common genetic variants for both atherosclerosis and T2DM (http://www.genome.gov/GWAStudies/). Several of the variants for coronary heart disease are within genes that are involved in glucose metabolism or are associated with T2DM, such as MTHFD1L and HNF1A. Thus far few studies have been conducted to examine such genetic variants and in those that have the findings are inconsistent. 6 -10 One major challenge for such studies is the difficulties inherent in establishing causality between genetic variants and complex disease in humans due to small gene effects, complex genetic structure, and environmental influences.
Clinical Perspective on p 201
A complementary approach to the identification of genetic components in human disease is to use animal models. One commonly used rodent model of atherosclerosis is the apolipoprotein E-deficient (Apoe Ϫ/Ϫ ) mouse, which develops all phases of atherosclerotic lesions seen in humans, progressing from the early foam cell stage to the advanced stage with a fibrous cap and necrotic lipid core. 11 We have observed that atherosclerosis susceptible C57BL/6 (B6) Apoe Ϫ/Ϫ mice develop significant hyper-glycemia when fed a Western-type diet. 12 In contrast, atherosclerosis-resistant BALB/cJ (BALB) Apoe Ϫ/Ϫ mice are highly resistant to hyperglycemia. 13 The concordant differences between the 2 Apoe Ϫ/Ϫ strains in susceptibility to atherosclerosis and to hyperglycemia provide an ideal model for investigating genetic connections between the phenotypes. In the present study, we performed quantitative trait locus (QTL) analysis on female mice from an intercross between B6.Apoe Ϫ/Ϫ and BALB.Apoe Ϫ/Ϫ mouse strains to investigate the genetic control of atherosclerosis and glucose homeostasis.
Methods

Mice
B6.Apoe Ϫ/Ϫ mice were purchased from the Jackson Laboratories. BALB. Apoe Ϫ/Ϫ mice at the N10 generation were generated in our laboratory, as previously described. 14 B6.Apoe Ϫ/Ϫ mice were crossed with BALB.Apoe Ϫ/Ϫ mice to generate F 1 s, which were intercrossed by brother-sister mating to generate a large F 2 population. Female F 2 mice were weaned at 3 weeks of age onto a rodent chow diet, and male F 2 mice were euthanized at the time of weaning. At 6 weeks of age, F 2 mice were started with a Western diet containing 21% fat, 34.1% sucrose, 0.15% cholesterol, and 19.5% casein (Harlan Laboratories, TD 88137) and maintained on the diet for 12 weeks. All this procedures were in accordance with current National Institutes of Health guidelines and approved by the University Animal Care and Use Committees.
Measurements of Plasma Glucose
Mice were bled twice: once before initiation of the Western diet and once at the end of the 12-weeks high-fat feeding period. Mice were fasted overnight before blood was drawn from the retroorbital venous plexus with the animals under isoflurane anesthesia. Plasma glucose was measured with a Sigma glucose (HK) assay kit, which was adapted for a microplate assay. Briefly, 10 L of plasma samples (plasma from high-fat diet fed mice was diluted 1:2 in distilled water) were mixed with 90 L of reagent in a 96-well plate. After a 15-minute incubation at room temperature, the absorbance at 340 nm was read on a Molecular Devices (Menlo Park, CA) plate reader.
Aortic Lesion Analysis
Atherosclerotic lesions in aortic root were measured as previously reported. 15 Briefly, the aortic root and adjacent heart were excised en bloc and embedded in optimal cutting temperature compound. Cross sections (10-m thick) of the vessel were collected, stained with oil red O and hematoxylin, and counterstained with fast green. Atherosclerotic lesion areas were quantified using an ocular lens with a square-micrometer grid on a light microscope. The lesion areas of 5 sections with the largest readings were averaged for each mouse and this average was used for statistical analysis.
Genotyping
Genomic DNA was isolated from the tails of mice by using the phenol/chloroform extraction and ethanol precipitation method. A total of 130 microsatellite markers covering all 19 autosomes and the X chromosome at an average interval of 12 cM were typed. Parental and F 1 DNA served as controls for each marker.
Statistical Analysis
QTL analysis was performed using J/qtl and Map Manager QTX software as previously described. 12, 15, 16 One thousand permutations of trait values were run to define the genome-wide LOD (logarithm of odds) score threshold required to be significant or suggestive for each specific trait. Loci that exceeded the 95th percentile of the permutation distribution were defined as significant (PϽ0.05) and those exceeding the 37th percentile were suggestive (PϽ0.63) according to the criteria recommended by the genetics community in 2003. 17 
Results
Trait Value Distributions
Fasting plasma glucose levels of 266 F 2 mice before and after 12 weeks on the Western diet, atherosclerotic lesions in the aortic root, and body weight were measured. As shown in Figure 1 , values of fasting plasma glucose levels on both chow and Western diets, log-transformed atherosclerotic lesion sizes, and body weight approach normal distributions. These data were analyzed to identify chromosomal regions segregating with the traits. Those loci exhibiting significant linkage and suggestive linkage are presented in Table 1 .
Atherosclerotic Lesion Size
Four significant QTLs, located on chromosomes (Chr) 1, 2, 5, and 9, and 1 suggestive QTL on Chr4, were identified for atherosclerotic lesion sizes ( Figure 2 ). Details of the QTLs detected, including locus name, LOD score, 95% confidence interval (CI), peak location, genome-wide significance probability value, high allele, and mode of inheritance are presented in Table 1 . The 2 significant QTLs on Chr1 and Chr9 replicated the previously reported QTLs, Ath1 and Ath29, respectively. 15, 18 The other 2 significant QTLs were novel. The Chr2 locus had a significant LOD score of 3.77 and a genome-wide significant probability value of 0.026. It peaked at 52.2 cM and did not overlap in the confidence interval with known mouse atherosclerosis QTLs. We named it Ath41 accord-ing to the QTL nomenclature for mouse atherosclerotic lesions. The Chr5 locus had a highly significant LOD score of 5.69 and a genome-wide probability value of Ͻ0.001. Its peak appeared at 54.7 cM. We named it Ath42. The Chr4 locus had a suggestive LOD score of 2.8 and peaked at 63.3 cM. This QTL was partially overlapping with Athsq1, an atherosclerotic lesion locus identified in a (MOLF/EiϫB6.Ldlr Ϫ/Ϫ )ϫB6.Ldlr Ϫ/Ϫ backcross. 19 Paradoxically, the BALB allele was associated with increased lesion size, whereas the B6 allele was associated with decreased lesion size ( Table 2 ). In contrast, for the 4 significant QTLs, the B6 allele was the high allele that increased lesion size and the BALB allele was the low one that reduced lesion size. Ath42 affected atherosclerotic lesion size in a dominant mode of inheritance, whereas other QTLs exhibited an additive effect on the trait.
Fasting Glucose Levels
For fasting glucose on the chow diet, 4 significant QTLs on Chr1, Chr5, and Chr12, and 2 suggestive QTLs on Chr9 and Chr15 were identified ( Figure 3 ). The significant locus on distal Chr1 and the 2 suggestive loci on Chr9 and Chr15 replicated the previously reported QTLs, Bglu3, a suggestive Plasma glucose levels were measured before (chow) mice were started on the Western diet and at the end of the 12-week Western diet (West) feeding period. Blood was drawn from overnight-fasted mice.
QTL indicates quantitative trait locus; LOD, logarithm of odds; and CI, confidence interval. *QTLs were named if they were significant or if they overlapped with previously reported suggestive ones. The nomenclature of Ath was for atherosclerosis QTLs, and Bglu for blood glucose QTLs. The newly identified QTLs are underlined to easily distinguish them from known ones.
†LOD scores were obtained from QTL analysis. The suggestive and significant LOD score thresholds were determined by 1000 permutation tests for each trait. Suggestive and significant LOD scores were 2.087 and 3.458, respectively, for atherosclerosis; 2.071 and 3.428 for plasma glucose on the chow diet; 2.084 and 3.423 for glucose on the Western diet, and 2.099 and 3.486 for body weight.
‡95% Confidence interval in cM obtained from a whole genome QTL scan. §QTL peak position in cM.
The P values reported represent the level of genome-wide significance as they were generated based on genome-wide permutation tests. ¶Mode of inheritance was defined according to allelic effect at the nearest marker of a QTL. **Significant LOD scores.
locus on Chr9 (now named Bglu14), and Fbg2, respectively ( Table 1 ). The significant QTLs on the middle portion of Chr1, Chr5, and Chr12 were novel. The LOD score plot for Chr1 displayed 2 distinct peaks, located approximately 14 cM apart ( Figure 3 ). The distal QTL peaked at 74.3 cM, overlapping with Bglu3, identified in a B6ϫC3H Apoe Ϫ/Ϫ F 2 cross. 12 The proximal peak occurred at 60.3 cM with a LOD score reaching 3.94. We named this QTL Bglu12 to represent a The number in the bracket represents the number of progeny with a specific genotype at a specific marker. ANOVA was used to determine the significance level (P value) of differences for a specific phenotype among progeny with 3 different genotypes at a specific marker.
Measurements are expressed as meanϮSD. The units for these measurements are m 2 /section for atherosclerotic lesions; mg/dL for glucose; and g for body weight.
BB indicates homozygous for B6 alleles at the linked peak marker; CC, homozygous for BALB alleles; BC, heterozygous for B6 and BALB alleles at the peak marker. significant mouse QTL for fasting glucose. The Chr5 locus had a highly significant LOD score of 6.72 and peaked at 47.3 cM. We named it Bglu13. The QTL on Chr9 had a suggestive LOD score of 3.06, and overlapped with a suggestive locus near D9mit229 (26.8 cM) for fasting glucose levels identified in a B6 x KK-Ay F2 cross. 20 We designated this QTL as Bglu14 as it has not been named. The QTL on Chr12, named Bglu15, had a significant LOD score of 3.43 and peaked at 10 cM. Bglu15 is close to the centromere compared with Fbg-1, which is located in the middle portion of Chr12 between D12mit4 (35.5 cM) and D12mit227 (38.4 cM). 21 The suggestive QTL on Chr15 overlapped with Fbg-2 near D15Mit87 (16.7 cM), identified in (BALBϫKK/Ta)ϫKK/Ta backcross. 21 For fasting glucose on the Western diet, 2 significant QTLs on Chr1 and Chr5 and 1 suggestive QTL on Chr8 were identified ( Figure 4 ). The Chr1 QTL replicated Bglu3, and the Chr5 replicated Bglu13. The Chr8 locus overlapped with Giq1, a locus with a strong influence on the late phase of glucose tolerance test identified in a B6ϫKK-A cross. 22 Bglu13 affected fasting glucose levels on both chow and Western diets in a dominant mode of inheritance, whereas all other QTLs exhibited an additive effect on the trait except for the QTL on Chr9 and Chr15 that affected glucose levels in a recessive and a heterosis mode, respectively ( Table 2 ).
Body Weight
One significant QTL on distal Chr1 and 2 suggestive QTLs on Chr9 and Chr19 were identified for body weight ( Figure  5 ). The Chr1 QTL overlaps with Wt3q2 and Wt6q2 for body weight mapped in 2 F 2 populations created from a selection Figure 3 . A genome-wide scan to search for loci for fasting plasma glucose levels when the F 2 mice were fed the chow diet. Blood was collected from overnight fasted F 2 mice the day before being started on the Western diet. LOD indicates logarithm of odds. and an inbred mouse lines, 23 Bw8q1 originally mapped in a B6ϫA/J intercross 24 and then replicated in a BxH Apoe Ϫ/Ϫ F 2 cross, 12 and Nob3 for body fat body weight and blood glucose mapped in NZOϫB6 F 2 females. 25 The Chr9 locus overlaps with W10q13 mapped in an M16iϫL6 intercross, 26 Do2 for dietary obese mapped in 2 crosses derived from AKR/J and SWR/J mice, 27 and Obq18 for obesity mapped in B6ϫ129 F 2 females. 28 The Chr19 locus corresponds to Wtmq9 mapped in a B6ϫC3H Apoe Ϫ/Ϫ intercross, 29 W3q14 from an M16iϫL6 F 2 intercross, 26 and Abfw4 for abdominal fat mapped in DU6iϫDBA/2 intercross. 30
Coincident QTLs for Atherosclerosis and Fasting Glucose
LOD score plots for chromosome 5 show that the QTL for atherosclerosis (Ath42) coincided with the QTL for fasting glucose (Bglu13) in the confidence interval ( Figure 6 ). Both loci exhibited a dominant effect from the B6 allele on atherosclerotic lesions or fasting glucose levels ( Table 2) . LOD score plots for chromosome 1 show partial overlapping of the QTL for atherosclerosis (Ath1) with the QTLs for fasting glucose (Bglu3) and body weight in the confidence interval (Figure 7) . The B6 allele was associated with increased atherosclerotic lesions and decreased glucose levels and body weight, whereas the BALB allele was associated with decreased lesions and increased glucose levels and body weight ( Table 2 ). Ath29 was also partially overlapping with Bglu14 in the confidence interval on the Chr9 (Table 1) .
Discussion
In the present study, we have identified 5 loci contributing to the development of atherosclerosis, 6 loci to fasting glucose levels on the chow diet, 3 loci contributing to fasting glucose levels on the Western diet, and 3 loci for body weight in an intercross between B6 and BALB.Apoe Ϫ/Ϫ mouse strains. Moreover, we have observed the colocalization of QTLs for atherosclerotic lesions and for plasma glucose levels on chromosomes 1, 5, and 9.
B6 and BALB are prototype mouse strains for genetic studies of atherosclerosis. In pioneering studies of recombinant inbred strains derived from the 2 strains, as well as from B6 and C3H/HeJ, Paigen et al 18 identified the first atherosclerosis susceptibility locus, Ath-1. Subsequent studies of female F 2 and N 2 progeny derived from the B6 and BALB strains demonstrates the segregation of Ath-1 with HDL cholesterol levels. 31 However, there are several limitations in those studies: First, the number rather than the size of atherosclerotic lesions was measured. Thus, atherosclerotic lesions were treated as a "qualitative trait" rather than a "quantitative trait." Second, the mapping was performed using a rather small numbers of animals, especially the recombinant inbred strains, thus the power for detecting susceptibility loci was low. Third, there were fewer polymorphic markers available at the time when the studies were conducted. Last, the diet-induced mouse model of atherosclerosis develops only small fatty streak lesions that are largely limited to the aortic root. 32 In contrast, Apoe-deficient mice develop all phases of atherosclerotic lesions in large and medium sized arteries seen in humans. 11 Our present work has extended the prior studies by finding five atherosclerosis QTLs, including Ath1. Among the five QTLs, Ath1, Athsq1, and Ath29, have been previously reported. 15, 18, 33 Tnfsf4 has been identified to be the causal gene of Ath1. 34 We recently have identified Rcn2, a calcium-binding protein in the endoplasmic reticulum, as a key regulator in oxidized phospholipid-induced cytokine production and a probable candidate gene of Ath29. 35 The confidence interval of Athsq1 is corresponding to human chromosome 9p21, a region that is associated with coronary heart disease. 36 -38 The QTL on chromosome 2, named Ath41, is close to Athla1, an atherosclerosis susceptibility locus mapped in a (PERAϫB6-Ldlr Ϫ/Ϫ )ϫB6-Ldlr Ϫ/Ϫ N 2 backcross mice. 39 Figure 5 . A genome-wide scan to search for loci for body weight. Mice were weighed the day being euthanized. LOD indicates logarithm of odds.
Athla1 is located in a more distal region (69 cM), and it increases lesion size only when homozygous for the B6 allele. Candidate genes for Ath41 include Dab2ip, Tfpi, and Slc38a11, which have been shown to be associated with coronary heart disease in humans. 40, 41, 42 We identified a major locus on chromosome 5, approximately between 40 -60 cM, which affected both atherosclerotic lesion size and fasting plasma glucose levels. We named it Ath42 for atherosclerotic lesions and Bglu13 for fasting glucose. As the 2 loci overlap significantly in the confidence interval, it is plausible to postulate that they share the same underlying causal gene. The present observation that both QTLs exhibited the same dominant B6 allele effect on the 2 different traits supports this speculation. Nevertheless, it is also likely that the 2 phenotypes are affected by 2 linked but unique genes residing in the QTL interval. The region from 40 -60 cM on chromosome 5 in the mouse corresponds to chromosomal regions of 4q13, 4q21, and 12q24 in humans. The 4q13 region has been shown to be associated with variations in metabolic traits, including blood glucose, 43, 44 and the 12q24 region is associated with coronary heart disease, 45, 46 metabolic syndrome, 47, 48 and type 1 and type 2 diabetes. 49 -51 One promising candidate gene in the region is Hnf1a, which encodes hepatocyte nuclear factor 1␣. One A/G SNP in exon 9 between B6 and BALB leads to amino acid substitution (P580R) in the Hnf1a protein. In humans, Hnf1a mutations are the most common cause of maturityonset diabetes of the young. 52 Polymorphisms in the Hnf1a gene are associated with risk for T2DM and coronary heart disease. 49, 53 The QTLs for plasma glucose and body weight on distal chromosome 1 have been reported previously in three separate mouse intercrosses, including 2 B6ϫC3H crosses deficient in Apoe, 12, 29 and a cross between New Zealand obese (NZO) and B6 mice. 25 The confidence interval of the QTLs overlaps with a region of linkage to type 2 diabetes found in multiple human populations that has been extensively examined by the International Chromosome 1q Type 2 Diabetes Consortium. 54 In the current cross, we have observed 2 distinct peaks of the linkage curve for plasma glucose on the chow diet with the distal peak at 74.3 cM and the proximal peak at 60.3 cM. The bootstrap test, an effective statistical method for defining the confidence interval of QTLs using simulation, 55 also indicated the existence of 2 QTLs for the trait on chromosome 1. We have named the proximal QTL Bglu12 to represent a new locus for fasting glucose in the mouse.
The QTLs for atherosclerosis (Ath1), fasting glucose (Bglu3), and body weight (BW8q1) overlap in the confidence interval on the distal chromosome 1 region. The B6 allele was associated with increased atherosclerosis but decreased glucose levels and body weight. Apoa2 is a major gene in the region that may contribute to variations in the traits. The QTL effect on body weight disappeared when the influence from the Apoa2 allele was eliminated. 56 On the other hand, transgene expression of Apoa2 in mice results in several phenotypes observed in T2DM, including glucose intolerance, insulin resistance, hypertriglyceridemia, and obesity. 57, 58 Apoa2 is also a major gene in the mouse that has a dramatic influence on plasma HDL cholesterol levels. 59 BALB mice have an Apoa2 b allele that elevates HDL cholesterol levels and B6 mice have an Apoa2 a allele that decreases HDL cholesterol levels. 60 High HDL cholesterol levels protect against atherosclerosis. Apcs, encoding serum amyloid P (SAP), is another candidate in the distal chromosome 1 region that may contribute to T2DM and atherosclerosis. Plasma SAP levels, which are primarily regulated by the Apcs gene, are correlated with blood glucose and body weight in a segregating F 2 population derived from B6 and C3H Apoe Ϫ/Ϫ mice. 12 In humans, SAP is significantly correlated with obesity, blood pressure, lipids, common and internal carotid wall thickness, and ankle-brachial index. 61 Cxcr4, Pask, Cntnap5a, Lct, and Pik3c2b are positional candidate genes for Bglu12. Variants of these genes have been found to be associated with susceptibility to T2DM, fasting glucose, or insulin resistance in humans. [62] [63] [64] [65] [66] [67] The QTL for fasting glucose on chromosome 9 was partially overlapping with the QTL for atherosclerosis. Sorl1, Rcn2, and Apoc3 are potential candidate genes in the region that may affect both atherosclerosis and T2DM. 35, 68, 69 For Bglu15, Adam17, encoding a disintegrin and metallopeptidase domain 17, and Ahr, encoding arylhydrocarbon receptor, are 2 likely candidate genes. Adam17 is involved in the shedding of the extracellular domain of cytokines, growth factors, receptors, or adhesion molecules. 70 Ahr signaling affects molecular clock genes associated with glucose metabolism, and Ahr deficiency enhances insulin sensitivity and reduces PPAR-␣ pathway activity. 71 In the present study, we have found some QTLs, such as Bglu3 and Bglu13, that influenced glucose levels when mice had normoglycemia on a chow diet also affected glucose levels when mice developed hyperglycemia on a high-fat diet. However, some other QTLs, such as Bglu12, Bglu14, and Bglu15 only exerted effect under a specific condition (the chow diet). Six QTLs were found for fasting plasma glucose when mice were fed the chow diet, whereas only 3 QTLs were detected when fed the Western diet. The reasons for the discrepancy in the results are unknown. One probable explanation is that the Western diet has a significant influence on plasma glucose levels, which might overwhelm the influence from genetic factors on the trait. In addition, the western diet induces some metabolic changes that suppress gene expression. We recently have found that there are much more differentially expressed genes in the aorta of 2 strains when fed a chow diet than a Western diet. 72 In summary, we have identified multiple QTLs contributing to the development of atherosclerosis and glucose homeostasis in a segregating F 2 population. The finding on the colocalization of QTLs for atherosclerosis and glucose has laid the basis for further study to determine whether they are controlled by the same genes or different unique genes in the QTL intervals.
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